CREDIT SUISSE AG/ - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 207 filers reported holding DENALI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$32,333,584
-30.3%
1,567,309
-0.4%
0.03%
-28.3%
Q2 2023$46,420,647
+29.7%
1,573,048
+1.3%
0.05%
+27.8%
Q1 2023$35,791,995
-16.1%
1,553,472
+1.3%
0.04%
-20.0%
Q4 2022$42,643,381
-13.8%
1,533,383
-4.8%
0.04%
-18.2%
Q3 2022$49,455,000
-14.3%
1,611,429
-17.8%
0.06%
-8.3%
Q2 2022$57,683,000
-8.5%
1,960,025
+0.1%
0.06%
+11.1%
Q1 2022$63,008,000
-28.1%
1,958,574
-0.3%
0.05%
+14.9%
Q4 2021$87,579,000
-12.4%
1,963,648
-0.9%
0.05%
-14.5%
Q3 2021$100,015,000
-35.2%
1,982,473
+0.8%
0.06%
-32.9%
Q2 2021$154,253,000
+38.0%
1,966,508
+0.4%
0.08%
+43.9%
Q1 2021$111,802,000
-4.8%
1,957,993
+39.6%
0.06%0.0%
Q4 2020$117,494,000
+3934.8%
1,402,750
+1626.2%
0.06%
+2750.0%
Q3 2020$2,912,000
+17.3%
81,264
-20.8%
0.00%0.0%
Q2 2020$2,483,000
+243.4%
102,647
+148.5%
0.00%
+100.0%
Q1 2020$723,000
-1.2%
41,307
-1.7%
0.00%0.0%
Q4 2019$732,000
-0.3%
42,004
-12.3%
0.00%0.0%
Q3 2019$734,000
-14.1%
47,898
+16.3%
0.00%0.0%
Q2 2019$854,000
-19.7%
41,187
-10.0%
0.00%0.0%
Q1 2019$1,063,000
+16.8%
45,764
+3.8%
0.00%0.0%
Q4 2018$910,000
+61.3%
44,091
+70.3%
0.00%0.0%
Q3 2018$564,000
+211.6%
25,894
+117.0%
0.00%
Q2 2018$181,00011,9340.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders